The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: A Vaccine Safety Datalink study

PURPOSE: To evaluate the safety of live attenuated influenza vaccine (LAIV) in children 2 through 17 years of age. METHODS: The study was conducted in 6 large integrated health care organizations participating in the Vaccine Safety Datalink (VSD). Trivalent LAIV safety was assessed in children who r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmacoepidemiol Drug Saf
Main Authors: Daley, Matthew F., Clarke, Christina L., Glanz, Jason M., Xu, Stanley, Hambidge, Simon J., Donahue, James G., Nordin, James D., Klein, Nicola P., Jacobsen, Steven J., Naleway, Allison L., Jackson, Michael L., Lee, Grace, Duffy, Jonathan, Weintraub, Eric
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6437673/
https://ncbi.nlm.nih.gov/pubmed/29148124
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pds.4349
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados